U.S. Other Utilities Stock News

NasdaqGS:VC
NasdaqGS:VCAuto Components

How Weaker Q2 Earnings, Buybacks And Micron Deal At Visteon (VC) Has Changed Its Investment Story

In the second quarter of 2026, Visteon reported sales of US$960 million and net income of US$49 million, while completing a US$262.05 million buyback program and signaling interest in further bolt-on acquisitions. At the same time, Visteon was named in Micron’s long-term automotive memory supply agreements, underlining its role in emerging AI-enabled vehicle platforms despite recent earnings pressure. We’ll now examine how Visteon’s weaker quarterly earnings alongside its Micron...
NYSE:ELS
NYSE:ELSResidential REITs

Is Stronger Q2 2026 Profitability Altering The Investment Case For Equity LifeStyle Properties (ELS)?

Equity LifeStyle Properties, Inc. reported past second-quarter 2026 results with sales of US$330.43 million, total revenue of US$397.82 million, and net income of US$96.32 million, all higher than the prior-year period. For the first half of 2026, the company’s revenue and net income growth versus 2025 underline how its portfolio continues to convert demand into higher earnings. We’ll now examine how this improved profitability, particularly the rise in quarterly net income, may influence...
NasdaqGM:WINA
NasdaqGM:WINASpecialty Retail

Does Winmark’s (WINA) Capital Return Focus Mask Pressure On Its Earnings Power?

Winmark Corporation recently reported its second-quarter and first-half 2026 results, showing slightly higher revenue year over year but modestly lower net income and earnings per share from continuing operations. Alongside earnings, the company affirmed a quarterly cash dividend of US$1.02 per share and confirmed completion of a long-running share repurchase program that retired more than 20% of its shares since 2011. Against this backdrop, we’ll explore how steady revenue, softer earnings,...
NasdaqGM:RZLV
NasdaqGM:RZLVSoftware

Rezolve AI (RZLV) Lands Zilch Deal As First Half Revenue Reaches US$127 Million

Rezolve AI (NasdaqGM:RZLV) reported a breakout first half of 2026, with preliminary revenues expected to hit a historic milestone. The company highlighted strong enterprise deployments as a key driver of its first half 2026 performance. Rezolve AI announced a new partnership with Zilch to embed its AI-driven commerce infrastructure into payments platforms. The Zilch agreement is expected to expand Rezolve AI's reach across major financial and payments channels. Rezolve AI enters the second...
NasdaqGS:GLXY
NasdaqGS:GLXYCapital Markets

Galaxy Digital (NasdaqGS:GLXY) Stock Still Trades At A Discount Following Its 362% Run

Galaxy Digital stock has given investors a very large 3 year return, yet the valuation checks now point to a more mixed picture, with the share price down sharply over shorter periods and only some metrics suggesting it still screens as undervalued. Galaxy Digital has delivered a very large 3 year return of about 362%, which puts the recent share price pullback into sharper context for anyone looking at entry points today. New commitments to large scale AI and high performance computing data...
NasdaqGS:SMTC
NasdaqGS:SMTCSemiconductor

Is Semtech (SMTC) Undervalued As AI Data Center Demand Meets Margin Risks?

Recent commentary around Semtech (SMTC) has picked up as investors focus on its role supplying semiconductor and Internet of Things solutions tied to AI data center build outs, while also weighing concerns about margins and goodwill. See our latest analysis for Semtech. At a share price of US$121.52, Semtech has given investors a 61.47% year to date share price return and a 124.37% total shareholder return over the past year. However, the 18.85% share price decline over the last month...
NasdaqGM:QCRH
NasdaqGM:QCRHBanks

Should QCRH’s Higher Net Income and Buybacks Prompt a Fresh Look at Its Capital Allocation Strategy?

In the second quarter of 2026, QCR Holdings, Inc. reported higher net interest income of US$67.92 million and net income of US$36.25 million, alongside net charge-offs of US$3.3 million, which were US$0.6 million lower than the prior quarter as the m2 portfolio winddown progressed. Over the same period, the company also completed a multi-quarter share repurchase program totaling 546,384 shares for US$43.29 million, underscoring an emphasis on capital return while earnings and credit metrics...
NYSE:SXT
NYSE:SXTChemicals

Sensient Technologies (SXT) Is Up 13.9% After Raising 2026 EPS Guidance And Confirming Dividend

Sensient Technologies Corporation recently reported past second-quarter 2026 results showing higher sales of US$462.08 million and net income of US$51.36 million, alongside raised full-year 2026 diluted EPS guidance to a range of US$4.10–US$4.20. The company’s stronger earnings and increased guidance were accompanied by an affirmed quarterly dividend of US$0.41 per share, underscoring ongoing capital returns to shareholders. Next, we will examine how Sensient’s upgraded earnings guidance...
NYSE:VPG
NYSE:VPGElectronic

Vishay Precision Group (VPG) Stock May Not Be A Bargain Despite Its 262% Run

Vishay Precision Group stock has delivered a very strong 262.2% return over the past year, yet the valuation picture is mixed because the Discounted Cash Flow (DCF) intrinsic value estimate points to a sizeable discount while traditional market multiples suggest the shares are expensive. The 262.2% one year return sets high expectations for what Vishay Precision Group needs to deliver to justify the current share price. Future cash flow growth and margin durability can support the DCF view...
NYSE:FUL
NYSE:FULChemicals

H.B. Fuller (FUL) Could Be 23% Undervalued Following Its Refinancing Move

Why H.B. Fuller’s refinancing move matters for stock watchers H.B. Fuller (FUL) recently overhauled key debt facilities, refinancing $420 million in term loans, expanding its revolving credit capacity, extending maturities to 2031 and trimming interest margins, a balance sheet shift investors are now assessing. See our latest analysis for H.B. Fuller. Despite the refinancing and a recent dividend affirmation, H.B. Fuller’s share price has been under pressure, with a 30 day share price return...
NasdaqGS:DASH
NasdaqGS:DASHHospitality

DoorDash (DASH) Stock Trades At A Premium To Fair Value

DoorDash stock has delivered a strong 103.1% gain over the past three years, yet its valuation checks currently point to a company that screens as expensive rather than a clear bargain. DoorDash has returned 103.1% over three years, which sets a high bar for any further upside to be justified by fundamentals. Efforts to roll out autonomous delivery robots and expand AI driven customer support may support growth expectations, while heavy investment requirements and execution risks in these...
NasdaqGS:ADI
NasdaqGS:ADISemiconductor

Analog Devices (ADI) Stock Looks Fully Priced With Strong Returns But Rich Earnings

Analog Devices stock has delivered a strong 141.5% total return over the past 5 years, yet the latest valuation checks suggest the shares now lean expensive rather than clearly cheap. A 141.5% return over 5 years highlights how strongly Analog Devices has rewarded long term shareholders, which raises the bar for any new upside from here. Investor focus on cash generation across the sector, illustrated by Texas Instruments planning lower capital spending to support free cash flow, can support...
NasdaqGM:SUPN
NasdaqGM:SUPNPharmaceuticals

How Investors Are Reacting To Supernus Pharmaceuticals (SUPN) Positive Earnings ESP And Renewed Beat Expectations

In the lead-up to its early August 2026 earnings release, Supernus Pharmaceuticals attracted attention after analysts highlighted its positive Earnings ESP and prior earnings outperformance. This heightened optimism around another potential earnings beat has sharpened focus on whether the company’s recent execution can support its longer-term CNS growth ambitions. With analysts pointing to a positive Earnings ESP as a key signal, we’ll now examine how this shapes Supernus Pharmaceuticals’...
NasdaqGS:JAZZ
NasdaqGS:JAZZPharmaceuticals

Should Anticipated Earnings Beat and Employer Award Recognition Require Action From Jazz Pharmaceuticals (JAZZ) Investors?

Jazz Pharmaceuticals recently reported that analysts had expected a very large year-over-year earnings increase to US$6.04 per share on revenues of about US$1.11 billion for the June 2026 quarter, alongside receiving a second consecutive Gold Stevie Award for Employer of the Year in the pharmaceutical industry. This combination of anticipated earnings strength and external recognition for workplace quality highlights both operational momentum and a culture that may support longer-term...
NYSE:AIZ
NYSE:AIZInsurance

Is Assurant (AIZ) Fully Priced Following Its Communications Leadership Change?

Assurant (AIZ) drew fresh attention after appointing Kelli Ertel as Chief Communications Officer and Chief of Staff on July 23, 2026. This move adds communications and brand leadership to her existing responsibilities. See our latest analysis for Assurant. Set against this leadership change, Assurant’s share price has climbed 17.6% over the past 90 days and its 1 year total shareholder return stands at 52.1%, which indicates that positive momentum has been building. If this kind of move has...
NYSE:SBSI
NYSE:SBSIBanks

Does Southside Bancshares (SBSI) Pairing Earnings Growth With Buybacks Reveal a New Capital Playbook?

Southside Bancshares, Inc. recently reported past second-quarter and first-half 2026 results showing higher net interest income and net income year-on-year, while also completing a US$35.36 million share repurchase program totaling 1,237,865 shares announced in July 2023. The combination of earnings growth and a fully executed buyback points to management’s focus on profitability and disciplined capital deployment, supported by lower net charge-offs of US$0.3 million in the quarter. With...
NYSE:MOD
NYSE:MODBuilding

3 Stocks Estimated To Be Up To 48% Below Their Intrinsic Value

In the last week, the United States market has been flat, but over the past 12 months, it has seen a 15% rise with earnings projected to grow by 17% annually. In this context of steady growth and positive forecasts, identifying stocks that are trading below their intrinsic value can present potential opportunities for investors seeking to capitalize on undervalued assets.
NasdaqGM:SYPR
NasdaqGM:SYPRAuto Components

Top Penny Stocks To Watch In July 2026

Over the last 7 days, the market has remained flat, but over the past 12 months, it has risen by 15%, with earnings forecasted to grow by 17% annually. In light of these conditions, investors might find value in stocks that combine financial strength with growth potential. Penny stocks, while often associated with smaller or newer companies, can offer unique opportunities for those looking to uncover hidden gems in the market.
NasdaqGS:OZK
NasdaqGS:OZKBanks

First Financial Bancorp And Two Other Top Dividend Stocks For Your Portfolio

In the last week, the United States market has been flat, though it is up 15% over the past year with earnings projected to grow by 17% annually in the coming years. In light of these conditions, identifying strong dividend stocks like First Financial Bancorp can be a strategic approach for investors seeking stable income and potential growth in their portfolios.
NYSE:LOB
NYSE:LOBBanks

Live Oak Bancshares (LOB) Could Be 6% Undervalued After Strong Q2 Earnings

Why Live Oak Bancshares Earnings Matter For Investors Live Oak Bancshares (LOB) just posted second quarter 2026 results, with higher net interest income, net income and earnings per share compared with a year earlier. Net charge offs also declined over the same period. See our latest analysis for Live Oak Bancshares. The latest earnings release and lower net charge offs appear to support renewed confidence in Live Oak Bancshares, with the share price at $42.18 and a year to date share price...
NasdaqGS:ALNY
NasdaqGS:ALNYBiotechs

GSK Stock Jumps As 3 Biotech Names Gain From Its R And D Reset

GSK has just announced a £1.9b cost cutting program alongside fresh investment in UK life sciences, and the market reaction has been quick, with the stock up 6% on the news. When a major pharmaceuticals and biotechnology group reshapes its R&D footprint and focuses on phase 3 trials, it can ripple across the sector. Some companies may see new competitive pressure, while others may benefit from partnership, supply chain or sentiment shifts. This article looks at 3 stocks from our...
NYSE:CAAP
NYSE:CAAPInfrastructure

Do June’s Softer Traffic Numbers Alter Corporación América Airports’ Long-Term Volume Story (CAAP)?

Corporación América Airports S.A. has reported past operating results for June 2026, with monthly passengers of 6,602,000 versus 6,885,000 a year earlier, alongside lower cargo volumes and aircraft movements, while year-to-date traffic, cargo, and movements were slightly higher than the prior-year period. This mix of softer monthly figures but firmer year-to-date trends highlights how traffic performance can differ over short and longer periods across the company’s network. With June’s...
NasdaqGS:HCSG
NasdaqGS:HCSGCommercial Services

Healthcare Services Group (HCSG) Is Down 8.0% After Profit Rebound And Capital Moves Is The Bull Case Changed?

In July 2026, Healthcare Services Group, Inc. reported second-quarter results showing higher sales of US$470.81 million and net income of US$22.7 million after a loss a year earlier, completed a US$35.64 million share buyback, and filed a US$56.08 million ESOP-related shelf registration for 2,500,000 common shares. This combination of a profit rebound, recent share repurchases, and new employee share issuance highlights how Healthcare Services Group is reshaping its capital structure while...